These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
95 related articles for article (PubMed ID: 7363377)
1. Reversed-phase high-performance liquid chromatographic determination of gliclazide in human plasma. Kimura M; Kobayashi K; Hata M; Matsuoka A; Kaneko S; Kitamura H; Kimura Y Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):344-6. PubMed ID: 7363377 [No Abstract] [Full Text] [Related]
2. Measurement of gliclazide in plasma by radial compression reversed-phase liquid chromatography. Charles BG; Ravenscroft PJ Clin Chem; 1984 Nov; 30(11):1789-91. PubMed ID: 6488522 [TBL] [Abstract][Full Text] [Related]
3. [Gas-liquid chromatographic method for determination of plasma gliclazide (author's transl)]. Kimura M; Kobayashi K; Takashima S; Ino T; Hata M; Matsuoka A; Kaneko S; Kimura Y Rinsho Byori; 1980 Jan; 28(1):63-6. PubMed ID: 7373877 [No Abstract] [Full Text] [Related]
4. High-performance liquid chromatographic determination of gliclazide in human plasma. Poirier JM; Perez M; Cheymol G J Chromatogr; 1987 Oct; 421(1):223-6. PubMed ID: 3429572 [No Abstract] [Full Text] [Related]
5. [High-performance liquid chromatographic determination of gliclazide (oral hypoglycemic agent) in serum--trial of sensitive fluorometric determination]. Igaki A; Kobayashi K; Kimura M; Sakoguchi T; Hashimoto M; Matsuoka A Rinsho Byori; 1986 Feb; 34(2):201-5. PubMed ID: 3702090 [No Abstract] [Full Text] [Related]
6. Determination of gliclazide in human serum by high-performance liquid chromatography using an anion-exchange resin. Kimura M; Kobayashi K; Hata M; Matsuoka A; Kitamura H; Kimura Y J Chromatogr; 1980 Oct; 183(4):467-73. PubMed ID: 7430298 [TBL] [Abstract][Full Text] [Related]
7. [Determination of serum gliclazide (hypoglycemic drug) by high performance liquid chromatography, using diaion CDR-10 column]. Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Takashima S; Mimura K; Matsuoka A; Kimura Y Rinsho Byori; 1981 Sep; 29(9):895-901. PubMed ID: 7328815 [No Abstract] [Full Text] [Related]
8. Influence of blood proteins on biomedical analysis. IX. Protective effects of human serum proteins on anion-induced degradation of gliclazide. Kobayashi K; Igaki A; Kimura M; Sakoguchi T; Shimosawa M; Matsuoka A Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2957-62. PubMed ID: 3769097 [No Abstract] [Full Text] [Related]
9. Gas chromatographic determination of the hypoglycaemic agent gliclazide in plasma. Maeda T; Yamaguchi T; Hashimoto M J Chromatogr; 1981 May; 223(2):357-63. PubMed ID: 7251790 [TBL] [Abstract][Full Text] [Related]
10. Determination of a new hypoglycemic drug, gliclazide, in human serum by radioimmunoassay. Suzuki H; Miki M; Sekine Y; Kagemoto A; Negoro T; Maeda T; Hashimoto M J Pharmacobiodyn; 1981 Mar; 4(3):217-25. PubMed ID: 7252771 [TBL] [Abstract][Full Text] [Related]
11. Influence of blood proteins on biomedical analysis. III. Pharmacokinetics and protein binding of gliclazide. Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Hata M; Matsuoka A J Pharmacobiodyn; 1981 Jun; 4(6):436-42. PubMed ID: 7288560 [TBL] [Abstract][Full Text] [Related]
12. [Adsorption of gliclazide on the collodion membrane in ultrafiltration]. Kobayashi K; Kimura M; Hase A; Sakoguchi T; Hashimoto M; Matsuoka A Rinsho Byori; 1985 May; 33(5):569-71. PubMed ID: 4057640 [No Abstract] [Full Text] [Related]
13. Comparison of capillary electrophoresis with HPLC for diagnosis of factitious hypoglycemia. Paroni R; Comuzzi B; Arcelloni C; Brocco S; de Kreutzenberg S; Tiengo A; Ciucci A; Beck-Peccoz P; Genovese S Clin Chem; 2000 Nov; 46(11):1773-80. PubMed ID: 11067812 [TBL] [Abstract][Full Text] [Related]
14. [Inhibitory effect of gliclazide on platelet adhesiveness and aggregation in alloxan diabetic rabbits (author's transl)]. Kuwashima J; Tsuboi T; Komiya M; Fujitani B; Nakamura K; Maeda J; Kaneko H; Yoshida K; Shimizu M Yakugaku Zasshi; 1979 Jan; 99(1):59-64. PubMed ID: 430345 [No Abstract] [Full Text] [Related]
15. Influence of blood proteins on biomedical analysis. IV. Degradation of gliclazide in albumin-removed human serum and its protective effect of albumin. Kobayashi K; Kimura M; Sakoguchi T; Kitani Y; Hase A; Matsuoka A J Pharmacobiodyn; 1981 Nov; 4(11):886-92. PubMed ID: 7328490 [No Abstract] [Full Text] [Related]
16. A screening test for detecting sulfonylureas in plasma. Shenfield GM; Boutagy JS; Webb C Ther Drug Monit; 1990 Jul; 12(4):393-7. PubMed ID: 2118693 [TBL] [Abstract][Full Text] [Related]
17. Influence of blood proteins on biomedical analysis. II. Interaction of gliclazide with bovine serum albumin. Kobayashi K; Sakoguchi T; Kimura M; Kitani Y; Matsuoka A Chem Pharm Bull (Tokyo); 1981 Feb; 29(2):573-7. PubMed ID: 7273254 [No Abstract] [Full Text] [Related]
18. Influence of blood proteins on biomedical analysis. V. Effect of ethyl alcohol on gliclazide-binding with bovine serum albumin. Kobayashi K; Kimura M; Sakoguchi T; Hase A; Matsuoka A Chem Pharm Bull (Tokyo); 1982 Mar; 30(3):1077-80. PubMed ID: 7094168 [No Abstract] [Full Text] [Related]
19. Pharmacokinetics of gliclazide in healthy and diabetic subjects. Kobayashi K; Kimura M; Sakoguchi T; Hase A; Matsuoka A; Kaneko S J Pharm Sci; 1984 Dec; 73(12):1684-7. PubMed ID: 6396398 [TBL] [Abstract][Full Text] [Related]
20. Simultaneous determination of oral antidiabetic drugs in human plasma using microextraction by packed sorbent and high-performance liquid chromatography. Viana IM; Lima Pde P; Soares CD; Fernandes C J Pharm Biomed Anal; 2014 Aug; 96():241-8. PubMed ID: 24780925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]